$PG

Jejurikar Shailesh sold $888K of PG

Jejurikar Shailesh (Chairman, President and CEO) sold 6,176 shares of PROCTER & GAMBLE Co (PG) at $143.79 ($0.89M total) on 2026-08-20.

Original reporting
SEC EDGAR · Jejurikar Shailesh
Published Aug 24, 2026, 7:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 24, 2026, 8:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PG
Neutral
medium confidence
Mentioned
$PG
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PGNeutralLow
01

Why it matters

The sale is a primary disclosure; modest size limits market impact.

02

Market read

Routine insider sale with limited trading relevance.

03

What to watch

CEO may be reallocating capital; no change in company fundamentals.

Relevance 5/10Novelty 4/10Timing: post filing

Background

SEC Form 4 disclosed the insider transaction.

Company-level read

Ticker impact

$PGNeutralMedium confidence
Context

CEO Shailesh Jejurikar sold 6,176 shares of Procter & Gamble for $888K, reducing his stake to 39,326 shares.

Expected impact

Potential slight downward pressure if market interprets as negative signal.

Evidence & confidence

Form 4 filing is primary source; $888K sale by CEO is material enough for short-term traders but not large enough to drive major price moves.

Market effects

Minimal impact on consumer staples sector.

None

Low

Counterpoint

Insider sell could be routine diversification, not a negative signal.

Key entities

  • Procter & Gamble Co

    Consumer goods conglomerate (ticker PG).

  • Shailesh Jejurikar

    Chairman, President and CEO of Procter & Gamble.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PGMed

Evercore Upgrades Procter & Gamble (PG) to Outperform with Raise

Evercore ISI upgraded Procter & Gamble (PG) to Outperform, raising its price target to $166. The firm cited improved U.S. execution, stabilizing category volumes, and positive reorganization outcomes. PG's fiscal first-quarter organic sales growth forecast was lifted to 3%, surpassing consensus estimates. The company offers a 2.84% dividend yield with a 61% payout ratio, and GuruFocus rates it modestly undervalued.

$PGHigh

Procter & Gamble could face new cost problem

Procter & Gamble (PG) shares rose 1.5-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved market share and cost pressures. Evercore had been cautious due to PG's underperformance on Amazon and rising costs from oil, shipping, and tariffs, which squeezed margins. The upgrade suggests a 14% upside from the previous close.

$PGHigh

Procter & Gamble could face new cost problem amid oil, shipping, tariff pressures

Procter & Gamble (PG) shares rose 1.5%-2% after Evercore ISI upgraded it to Outperform with a $166 price target, citing improved e-commerce performance and higher sales growth estimates. The firm had previously been cautious due to cost pressures from oil, shipping, and tariffs, but now expects PG to stop losing U.S. e-commerce market share and achieve 4% sales growth by fiscal 2027. PG's dividend yield is 2.9%, and the company has increased its dividend for 70 consecutive years.

$PGLow

Access Proposal at Procter & Gamble

Institutional Shareholder Services (ISS) recommended Procter & Gamble (P&G) shareholders vote 'for' a proposal opposed by the company's board. The proposal, brought by the National Legal and Policy Center (NLPC), aims to preserve shareholder access rights. P&G argues the vote is premature, as the SEC has proposed repealing the rule enabling such proposals. The vote is scheduled for October 13.